Circ-PITX1 Promotes the Progression of Non-Small Cell Lung Cancer Through Regulating the miR-1248/CCND2 Axis

被引:16
|
作者
Yue, Qianyu [1 ]
Xu, Yanyan [1 ]
Deng, Xiaoli [1 ]
Wang, Shenglan [1 ]
Qiu, Jingman [1 ]
Qian, Baojiang [1 ]
Zhang, Yunhui [1 ]
机构
[1] Kunming Univ Sci & Technol, Dept Pulm & Crit Care Med, Peoples Hosp Yunnan Prov 1, Affiliated Hosp, 157 Jinbi Rd, Kunming 650032, Yunnan, Peoples R China
来源
ONCOTARGETS AND THERAPY | 2021年 / 14卷
关键词
non-small cell lung cancer; circ-PITX1; miR-1248; CCND2; DOWN-REGULATION; PROLIFERATION; INVASION; MIGRATION; CIRCRNA;
D O I
10.2147/OTT.S286820
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Circular RNA (circRNA) is a key regulator of cancer, and it has been proved to be involved in the regulation of cancer progression including non-small cell lung cancer (NSCLC). Circ-PITX1 was found to be a significantly upregulated circRNA in NSCLC, and its role and potential mechanism in NSCLC progression deserve further investigation. Methods: The expression levels of circ-PITX1, microRNA (miR)-1248 and cyclin D2 (CCND2) were examined by quantitative real-time PCR (qRT-PCR). Cell proliferation, apoptosis, cell cycle process, migration and invasion were determined using cell counting kit 8 (CCK8) assay, colony formation assay, flow cytometry, wound healing assay and transwell assay. Xenograft models were built to explore the role of circ-PITX1 in NSCLC tumor growth in vivo. The glycolysis and glutamine metabolism of cells were assessed by detecting the consumptions of glucose and glutamine, cell extracellular acidification rate (ECAR), and the productions of lactate, alpha-ketoglutaric acid (alpha-KG) and ATP. The protein levels of hexokinase 2 (HK-2), glutaminase 1 (GLS1) and CCND2 were tested by Western blot (WB) analysis. Dual-luciferase reporter assay and RIP assay were employed to verify the interaction between miR-1248 and circ-PITX1 or CCND2. Results: Circ-PITX1 was upregulated in NSCLC and its silencing could inhibit the proliferation, migration, invasion, cell cycle process, glycolysis, glutamine metabolism, and promote the apoptosis of NSCLC cells in vitro, as well as reduced tumor growth in vivo. In the terms of mechanism, we found that circ-PITX1 could act as a sponge of miR-1248, and miR-1248 could target CCND2. In addition, miR-1248 inhibitor reversed the inhibitory effect of circ-PITX1 knockdown on NSCLC progression. Similarly, CCND2 overexpression also reversed the suppressive effect of miR-1248 on NSCLC progression. Moreover, circPITX1 positively regulated CCND2 expression by sponging miR-1248. Conclusion: Circ-PITX1 served as a sponge of miR-1248 to promote NSCLC progression by upregulating CCND2.
引用
收藏
页码:1807 / 1819
页数:13
相关论文
共 50 条
  • [41] CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis
    Yumeng Cui
    Xiaojie Wu
    Jie Jin
    Weiling Man
    Jie Li
    Xiang Li
    Yanghua Li
    He Yao
    Rongbin Zhong
    Shiyun Chen
    Jiahui Wu
    Tianhao Zhu
    Yanli Lin
    Junjie Xu
    Youliang Wang
    [J]. Molecular Cancer, 22
  • [42] FRS2 promotes the progression of non-small cell lung cancer
    Gao, Jingpeng
    Wang, Li
    Jiang, Yifei
    Qian, Juanjuan
    Mo, Weiqiang
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 758 - 765
  • [43] LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis
    Luo, Xiping
    Zhou, Juan
    Quan, Lingli
    Liang, Yanchao
    Chen, Fangwei
    Liu, Shuangbo
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (11)
  • [44] LncRNA TTN-AS1 Promotes Progression of Non-Small Cell Lung Cancer via Regulating miR-491-5p/ZNF503 Axis
    Qi, Guanbin
    Li, Lei
    [J]. ONCOTARGETS AND THERAPY, 2020, 13 : 6361 - 6371
  • [45] lncRNA FOXD3-AS1 promotes the progression of non-small cell lung cancer by regulating the miR-135a-5p/CDK6 axis
    Guo, Haiyan
    Lin, Shufang
    Gan, Zhenyong
    Xie, Jinglian
    Zhou, Jiaming
    Hu, Ming
    [J]. ONCOLOGY LETTERS, 2021, 22 (06)
  • [46] MiR-520b promotes the progression of non-small cell lung cancer through activating Hedgehog pathway
    Liu, Xiaoming
    Liu, Jichun
    Zhang, Xuekang
    Tong, Yuben
    Gan, Xin
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (01) : 205 - 215
  • [47] Nrf2 promotes progression of non-small cell lung cancer through activating autophagy
    Wang, Jing
    Liu, Zhiyan
    Hu, Tinghua
    Han, Lili
    Yu, Shuo
    Yao, Yu
    Ruan, Zhiping
    Tian, Tao
    Huang, Tianhe
    Wang, Mincong
    Jing, Li
    Nan, Kejun
    Liang, Xuan
    [J]. CELL CYCLE, 2017, 16 (11) : 1053 - 1062
  • [48] Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway
    Zhao, Min
    Ma, Wei
    Ma, Chaonan
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2020, 129
  • [49] High hsa_circ_0020123 expression indicates poor progression to non-small cell lung cancer by regulating the miR-495/HOXC9 axis
    Bi, Rui
    Wei, Wei
    Lu, Yunhui
    Hu, Fengqing
    Yang, Xuhui
    Zhong, Yuan
    Meng, Lifei
    Wang, Mingsong
    Jiang, Lianyong
    Xie, Xiao
    [J]. AGING-US, 2020, 12 (17): : 17343 - 17352
  • [50] Circ_0006006 facilitates non-small cell lung cancer progression by modulating miR-924/SRSF7 axis
    Xu, Qinfu
    Shi, Jiang
    Zhang, Long
    Sheng, Yanbing
    Zhang, Yang
    Chu, Dan
    Xu, Aiguo
    [J]. JOURNAL OF GENE MEDICINE, 2022, 24 (05):